General Manager at Sarchem Laboratories, Inc.

March 25, 2026

Sarchem Laboratories offers a combined 60 years of professional experience in the field of pharmaceutical intermediaries, specializing in custom synthesis. Founded in 1984 as a research center focused on anti-viral drugs, Sarchem Laboratories has expanded over the years to the adapting needs of the pharmaceutical, nutraceutical and medicinal industries to offer an extensive product list cultivated with passion and precision. With clients such as CROs, universities, government entities and pharmaceutical companies of varying sizes, Sarchem Laboratories has provided top quality custom synthesis for over 25 years globally.

Introduction

Pharmaceutical and biotech research programs rarely fail because of bad science. More often, they stall because of problems in the supply chain: a batch that misses purity specs, a delivery that slips three weeks, or a synthesis partner that stops communicating the moment a route hits a snag. These are operational failures, but they carry real scientific consequences.

Selecting the right custom synthesis partner for pharmaceutical research is one of the more consequential decisions a research team makes early in a program. This is not simply a procurement task. You are choosing an organization whose chemistry capability, documentation practices, and communication habits will directly shape the quality and pace of your work.

This article covers what to actually look for, not a list of marketing claims, but the specific technical and operational criteria that separate a reliable partner from one that looks capable until the project gets difficult.

Defining the Scope: What Custom Synthesis Covers

Custom synthesis applies whenever you need a compound that is unavailable from standard catalogues, or when catalogue availability exists but the purity, scale, isotopic labelling, or documentation falls short of your requirements. In pharmaceutical and biotech programs, common applications include:

Reference standards and characterised impurity markers for analytical method development
Pharmaceutical intermediates and API building blocks for lead optimisation campaigns
Isotopically labelled compounds for DMPK, metabolite identification, and pharmacokinetic studies
Novel scaffolds and proprietary structures for medicinal chemistry programs
Speciality reagents and non-commercial substrates for process chemistry scale-up

The technical complexity varies considerably. Some requests involve a single functional group transformation. Others require multi-step sequences with asymmetric induction, sensitive protecting group strategies, or controlled stereochemistry at multiple centres. A capable custom synthesis services biotech provider needs to be competent across the full range, not just at the simpler end.

Key Criteria for Evaluation

Route Design Capability, Not Just Execution

There is a meaningful difference between a lab that will run a route you provide and one that can design the route from scratch. For most pharmaceutical research projects, you want the latter.

A qualified pharmaceutical custom synthesis provider will review your target structure, propose multiple synthetic strategies, and discuss trade-offs before any chemistry begins, yield predictions, known problematic intermediates, and potential regulatory sensitivities around certain reagent classes. Ask whether route scouting is a formal service they offer. A hesitant answer is informative.

Analytical Infrastructure and Certificate of Analysis Standards

Chemistry without rigorous analytics produces results you cannot defend. Any serious pharmaceutical custom synthesis provider in the USA should routinely deliver: proton and carbon NMR, HPLC purity profiles with documented method parameters, LC-MS molecular weight confirmation, and Karl Fischer moisture analysis where applicable.

A properly constructed Certificate of Analysis includes the batch number, instrument references, analytical methods with acceptance criteria, purity results, and storage recommendations. If a provider cannot produce a clear, traceable CoA as a standard deliverable, not something generated on special request, that is a disqualifying issue regardless of cost.

Demonstrated Scale Flexibility

Research programs do not remain at a single scale. An initial synthesis of 50 mg for a binding assay may be followed six months later by a request for 300 g to support a rodent toxicology study. The best custom synthesis partner for pharmaceutical work will handle both without treating the latter as a completely new engagement.

Ask about their reactor inventory, low-temperature reaction capability, and whether the same team manages scale-up or hands the work off internally. A process that runs cleanly at 1 g routinely behaves differently at 100 g. Partners with genuine scale-up experience understand this and will say so plainly.

Regulatory Awareness from Day One

Not every research-stage project is heading toward an IND filing. But many are, and documentation habits established early are difficult to retrofit later. A custom synthesis partner in the USA working in pharmaceutical contexts should be conversant with ICH Q7 for API manufacturing, Q3A and Q3B for impurity profiling, and Q11 for drug substance development, even when current program requirements do not formally invoke these guidelines.

Ask whether they retain batch records, archive reference samples, and can supply sourcing documentation for key starting materials. These are either habits built into a lab’s operating culture, or they are not.

Intellectual Property Protection

Target structures and synthetic routes represent proprietary information. A credible pharmaceutical custom synthesis provider will execute a mutual NDA before technical discussions begin, not after you have described the compound or project context. More important than the legal document, however, is how information is actually managed day to day.

Ask about project compartmentalisation practices. Are client projects handled by separate teams? Is data access restricted by the project? A custom synthesis services biotech provider working with multiple companies in the same therapeutic area requires robust internal controls, not just paperwork.

Communication Discipline

This criterion rarely appears on formal evaluation frameworks, but experienced research teams know it matters as much as chemistry capability. A project that goes off-track can be managed if the partner communicates early and honestly. The same problem surfaced two weeks later, which cannot be recovered within a research timeline.

Before committing, ask how they handle project updates, route failures, and schedule changes. Who is the dedicated point of contact? Are written progress reports provided on a defined schedule? The answers indicate how that organisation behaves under pressure, which is exactly when you need predictability.

Regulatory and Safety Considerations

A synthesis partner introduces shared compliance obligations into your supply chain. Confirm that any custom synthesis partner in the USA you engage maintains current SDS documentation for all project compounds, holds appropriate DEA registration where controlled precursors are involved, and manages chemical waste under applicable EPA and state environmental regulations.

For high-potency or allergenic compounds, verify that adequate occupational hygiene controls are in place, including containment equipment, engineering controls, and personnel monitoring protocols. Contamination from inadequate handling has compromised more than a few pharmaceutical batches, sometimes without timely notification to the customer.

How Sarchem Laboratories USA Supports Pharmaceutical and Biotech Research

Sarchem Laboratories Inc. operates as a fully integrated custom synthesis partner for pharmaceutical science and biotech clients across North America and internationally. Our team of experienced synthetic chemists supports programs from milligram-scale exploratory chemistry through multi-hundred-gram production, with documented quality control at every stage.

As an established custom synthesis partner in the USA, Sarchem provides:

Confidential route development and feasibility assessment for novel and complex targets
Synthesis of pharmaceutical intermediates, impurity reference standards, and specialty research reagents
Full analytical characterisation with a traceable Certificate of Analysis for every delivered batch
Scale-flexible production from research quantities through early-phase development supply
Regulatory-aligned documentation suitable for IND-supporting and preclinical programs

Our custom synthesis services biotech clients work with us because we treat every project as a technical collaboration. Chemist-to-chemist consultation is a standard part of how we engage, not a premium tier. When a route encounters an obstacle, we communicate immediately and bring options, not just problems.

As a pharmaceutical custom synthesis provider,, our objective is straightforward: quality, transparency, and reliable timelines consistently.

Conclusion

The qualities that make a custom synthesis partner for pharmaceutical research genuinely valuable are not difficult to identify once you know what criteria matter. Technical range, analytical rigour, honest communication, and documentation discipline are the markers that distinguish a serious pharmaceutical custom synthesis provider from one that simply takes orders.

Apply these criteria before you share any structural information, before you have a hard timeline dependency, and before a delayed delivery creates a gap your program cannot absorb. A capable partner will welcome that scrutiny. It reflects the same standards they apply internally.

Sarchem Laboratories USA welcomes confidential inquiries about your synthesis requirements. Contact our team for a direct technical conversation and a no-obligation feasibility assessment.

Frequently Asked Questions

What documentation should a custom synthesis partner provide with each batch?

At minimum: a Certificate of Analysis with HPLC purity, NMR/MS structural confirmation, batch number, analytical methods, and storage conditions. Regulatory programs may also require starting material sourcing records.

How do I assess the technical capability of a custom synthesis services biotech provider before committing?

Request anonymised case studies in your chemistry class, review team credentials, and ask for sample CoA documents. Ask specifically how they handle route failures; the answer is usually revealing.

What scale can a typical custom synthesis partner in the USA realistically handle?

Most capable providers work with doses ranging from 10 mg to several hundred grams. Confirm scale-up experience, specifically milligram-scale synthesis and process-scale chemistry, requires different equipment, expertise, and process understanding.

Is a pharmaceutical custom synthesis provider subject to FDA oversight for research-stage work?

Research-stage synthesis is not under FDA jurisdiction. GMP manufacturing for IND or NDA support is. Confirm ICH Q7 alignment if regulatory-grade material or audit-ready batch documentation is required.

How should intellectual property be protected when sharing structures with a custom synthesis partner?

Execute a mutual NDA before disclosing any structural information. Verify internal data compartmentalisation practices separate project teams and restrict data access, not just the legal agreement itself.

How to Evaluate a Custom Synthesis Partner for Pharmaceutical and Biotech Research